Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Impact of previous COVID-19 on immune response after a single dose of BNT162b2 SARS-CoV-2 vaccine

View ORCID ProfileMaría Velasco, Ma Isabel Galán, Ma Luisa Casas, Elia Pérez-Fernández, Beatriz González-Piñeiro, Virgilio Castilla, View ORCID ProfileCarlos Guijarro, Working Group Alcorcón COVID-19
doi: https://doi.org/10.1101/2021.03.08.21253065
María Velasco
1Infectious Diseases and Research Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for María Velasco
  • For correspondence: mvelasco@fhalcorcon.es
Ma Isabel Galán
2Occupational Health Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
a
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ma Luisa Casas
3Laboratory Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
a
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elia Pérez-Fernández
4Research Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatriz González-Piñeiro
5Information System Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virgilio Castilla
6Medical Director, Hospital Universitario Fundación Alcorcón, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Guijarro
7Professor of Medicine. Rey Juan Carlos University. Internal Medicine Unit. Research, Innovation and Education Coordinator. Hospital Universitario Fundación Alcorcón, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos Guijarro
  • For correspondence: carlos.guijarro@urjc.es
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Immune response after a single-dose of BNT162b2 vaccine is markedly increased in health care workers with previous SARS-CoV2 exposure, as assessed by positive SARS-CoV2 IgG, particularly after moderate-severe COVID-19. These data may inform the priority of the boosting mRNA second dose in times of vaccine shortage.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

The study was conducted without registration as per hospital procedures

Funding Statement

Hospital Universitario Fundacion Alcorcon supported the study

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

HUFA IRB provided approval of the protocol on January 27th

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Full data are available at our hospital upon request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 10, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Impact of previous COVID-19 on immune response after a single dose of BNT162b2 SARS-CoV-2 vaccine
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Impact of previous COVID-19 on immune response after a single dose of BNT162b2 SARS-CoV-2 vaccine
María Velasco, Ma Isabel Galán, Ma Luisa Casas, Elia Pérez-Fernández, Beatriz González-Piñeiro, Virgilio Castilla, Carlos Guijarro, Working Group Alcorcón COVID-19
medRxiv 2021.03.08.21253065; doi: https://doi.org/10.1101/2021.03.08.21253065
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Impact of previous COVID-19 on immune response after a single dose of BNT162b2 SARS-CoV-2 vaccine
María Velasco, Ma Isabel Galán, Ma Luisa Casas, Elia Pérez-Fernández, Beatriz González-Piñeiro, Virgilio Castilla, Carlos Guijarro, Working Group Alcorcón COVID-19
medRxiv 2021.03.08.21253065; doi: https://doi.org/10.1101/2021.03.08.21253065

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (500)
  • Anesthesia (110)
  • Cardiovascular Medicine (1226)
  • Dentistry and Oral Medicine (205)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (526)
  • Epidemiology (9990)
  • Forensic Medicine (5)
  • Gastroenterology (496)
  • Genetic and Genomic Medicine (2430)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1632)
  • Health Policy (750)
  • Health Systems and Quality Improvement (632)
  • Hematology (247)
  • HIV/AIDS (528)
  • Infectious Diseases (except HIV/AIDS) (11840)
  • Intensive Care and Critical Care Medicine (623)
  • Medical Education (250)
  • Medical Ethics (73)
  • Nephrology (267)
  • Neurology (2266)
  • Nursing (139)
  • Nutrition (348)
  • Obstetrics and Gynecology (449)
  • Occupational and Environmental Health (532)
  • Oncology (1241)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (154)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (727)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (280)
  • Psychiatry and Clinical Psychology (2272)
  • Public and Global Health (4814)
  • Radiology and Imaging (832)
  • Rehabilitation Medicine and Physical Therapy (486)
  • Respiratory Medicine (649)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (224)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (123)
  • Urology (99)